Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Optimizing foundational factors reduces side effect risk
Because SIRVA results from incorrect injection technique, it is entirely preventable
AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk
Looking Ahead Continued efforts are needed to raise awareness of the NICE Guidelines among healthcare professionals
That's why we ensure every product, from IGF-1 LR3 to TB-500 (thymosin Beta-4), meets stringent quality controls
US$ 29.18
US$ 26.42
US$ 21.01
US$ 23.44
US$ 22.50
US$ 28.65
US$ 26.06
